Portuguese genetic testing firm CGC Genetics recently launched a Diabetes/Obesity Mutation Panel that it claims can be used for preventive purposes.
The new test is done by microarray hybridization and screens a total of 76 markers: 38 polymorphisms on genes or loci associated with diabetes and 38 associated with obesity.
According to CGC, the test can be used to identify which individuals may benefit from an early therapeutic intervention to prevent disease progression.